Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

45 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Treatment of relapsed multiple myeloma: Evidence-based recommendations.
Durer C, Durer S, Lee S, Chakraborty R, Malik MN, Rafae A, Zar MA, Kamal A, Rosko N, Samaras C, Valent J, Chaulagain C, Anwer F. Durer C, et al. Blood Rev. 2020 Jan;39:100616. doi: 10.1016/j.blre.2019.100616. Epub 2019 Aug 31. Blood Rev. 2020. PMID: 31500848 Review.
Liver failure due to relapsed myeloma and hepatic iron overload.
Chaulagain CP, Gonzalez A, Goldszer I, Caraballo L, Hoffman JE, Elson L, Diacovo MJ. Chaulagain CP, et al. Ecancermedicalscience. 2020 Apr 30;14:1028. doi: 10.3332/ecancer.2020.1028. eCollection 2020. Ecancermedicalscience. 2020. PMID: 32368253 Free PMC article.
Practical and cost-effective model to build and sustain a cardio-oncology program.
Sadler D, Chaulagain C, Alvarado B, Cubeddu R, Stone E, Samuel T, Bastos B, Grossman D, Fu CL, Alley E, Nagarajan A, Nguyen T, Ahmed W, Elson L, Nahleh Z. Sadler D, et al. Cardiooncology. 2020 Jul 16;6:9. doi: 10.1186/s40959-020-00063-x. eCollection 2020. Cardiooncology. 2020. PMID: 32690995 Free PMC article.
On demand plerixafor is safe and effective for hematopoietic progenitor cell mobilization in patients with light chain amyloidosis at risk for mobilization failure with G-CSF alone.
Hubben A, Dima D, Atieh T, Chaulagain C, Faiman B, Ferraro C, Mazzoni S, Williams L, Samaras C, Valent J, Sauter C, Anwer F, Khouri J. Hubben A, et al. Bone Marrow Transplant. 2023 May;58(5):610-612. doi: 10.1038/s41409-023-01938-0. Epub 2023 Feb 24. Bone Marrow Transplant. 2023. PMID: 36828957 Free PMC article. No abstract available.
Systemic AL amyloidosis: current approach and future direction.
Bou Zerdan M, Nasr L, Khalid F, Allam S, Bouferraa Y, Batool S, Tayyeb M, Adroja S, Mammadii M, Anwer F, Raza S, Chaulagain CP. Bou Zerdan M, et al. Among authors: chaulagain cp. Oncotarget. 2023 Apr 26;14:384-394. doi: 10.18632/oncotarget.28415. Oncotarget. 2023. PMID: 37185672 Free PMC article. Review.
Liquid biopsies and minimal residual disease in myeloid malignancies.
Allam S, Nasr K, Khalid F, Shah Z, Khan Suheb MZ, Mulla S, Vikash S, Bou Zerdan M, Anwer F, Chaulagain CP. Allam S, et al. Among authors: chaulagain cp. Front Oncol. 2023 May 5;13:1164017. doi: 10.3389/fonc.2023.1164017. eCollection 2023. Front Oncol. 2023. PMID: 37213280 Free PMC article. Review.
45 results